IMMUNOMODULATION
Clinical trials for IMMUNOMODULATION explained in plain language.
Never miss a new study
Get alerted when new IMMUNOMODULATION trials appear
Sign up with your email to follow new studies for IMMUNOMODULATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to outsmart drug-resistant liver cancer
Disease control Not yet recruitingThis study tests a three-drug combination (ivarmacitinib, camrelizumab, and apatinib) in 65 adults with advanced liver cancer that initially responded to immunotherapy but then stopped working. The goal is to see if adding a JAK inhibitor can re-sensitize the tumor to immune atta…
Matched conditions: IMMUNOMODULATION
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
Ear-Zapping device may tame brain swelling after injury
Knowledge-focused Not yet recruitingThis study tests a safe, non-invasive device that gently stimulates a nerve in the ear to see if it can reduce brain swelling and inflammation after a traumatic brain injury or stroke. Researchers will measure brain damage markers and inflammation levels in 60 adults over 7 days.…
Matched conditions: IMMUNOMODULATION
Phase: NA • Sponsor: Clinical Hospital Centre Zagreb • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC